title: Pleiotropic actions of forskolin result in phosphatidylserine exposure in primary trophoblasts.
abstract: Forskolin is an extract of the Coleus forskholii plant that is widely used in cell physiology to raise intracellular cAMP levels. In the field of trophoblast biology, forskolin is one of the primary treatments used to induce trophoblastic cellular fusion. The syncytiotrophoblast (ST) is a continuous multinucleated cell in the human placenta that separates maternal from fetal circulations and can only expand by fusion with its stem cell, the cytotrophoblast (CT). Functional investigation of any aspect of ST physiology requires in vitro differentiation of CT and de novo ST formation, thus selecting the most appropriate differentiation agent for the hypothesis being investigated is necessary as well as addressing potential off-target effects. Previous studies, using forskolin to induce fusion in trophoblastic cell lines, identified phosphatidylserine (PS) externalization to be essential for trophoblast fusion and showed that widespread PS externalization is present even after fusion has been achieved. PS is a membrane phospholipid that is primarily localized to the inner-membrane leaflet. Externalization of PS is a hallmark of early apoptosis and is involved in cellular fusion of myocytes and macrophages. We were interested to examine whether PS externalization was also involved in primary trophoblast fusion. We show widespread PS externalization occurs after 72 hours when fusion was stimulated with forskolin, but not when stimulated with the cell permeant cAMP analog Br-cAMP. Using a forskolin analog, 1,9-dideoxyforskolin, which stimulates membrane transporters but not adenylate cyclase, we found that widespread PS externalization required both increased intracellular cAMP levels and stimulation of membrane transporters. Treatment of primary trophoblasts with Br-cAMP alone did not result in widespread PS externalization despite high levels of cellular fusion. Thus, we concluded that widespread PS externalization is independent of trophoblast fusion and, importantly, provide evidence that the common differentiation agent forskolin has previously unappreciated pleiotropic effects on trophoblastic cells.
authors: Department of Physiology, University of Alberta, Edmonton, Alberta, Canada ; Women and Children's Health Research Institute, University of Alberta, Edmonton, Alberta, Canada.
authors: Meghan R
authors: MR
authors: Riddell
authors: Bonnie
authors: B
authors: Winkler-Lowen
authors: Yanyan
authors: Y
authors: Jiang
authors: Sandra T
authors: ST
authors: Davidge
authors: Larry J
authors: LJ
authors: Guilbert
mesh_terms: D002459:Cell Fusion; D045744:Cell Line, Tumor; D005576:Colforsin / Q000378:metabolism*; D006801:Humans; D010718:Phosphatidylserines / Q000378:metabolism*; D014327:Trophoblasts / Q000166:cytology* / Q000378:metabolism*
chemical_list: D010718:Phosphatidylserines; D005576:Colforsin